Sep 28, 2023 by James HalleyWhy Shares of Organogenesis Holdings Are Up ThursdayThe company said it learned that its products will again be covered by three Medicare Administrative Contractors.
Sep 27, 2023 by James HalleyWhy Shares of Soleno Therapeutics Dropped on WednesdayInvestors took profits a day after the clinical-stage biotech company's shares soared.
Sep 27, 2023 by James HalleyWhy Shares of Apellis Pharmaceuticals Were Down WednesdayA short-seller report sent the stock tumbling.
Sep 27, 2023 by James HalleyWhy Shares of Allakos Are Up WednesdayThe stock is bouncing back from a recent 52-week low.
Sep 26, 2023 by James HalleyWhy Shares of Vera Therapeutics Jumped TuesdayThe stock bounced back Tuesday from a three-month low it hit on Monday.
Sep 26, 2023 by James HalleyWhy Shares of Immunovant Are Soaring on TuesdayImmunovant sees strong potential for an autoimmune disorder therapy.
Sep 26, 2023 by James HalleyWhy Shares of Soleno Therapeutics Are Booming on TuesdaySoleno announced positive top-line results for DCCR, its lead therapy.
Sep 26, 2023 by James HalleyWhy Shares of Pliant Therapeutics Are Rising TuesdayThe company's lead therapy fared well in a phase 2a trial to treat two separate conditions.
Sep 24, 2023 by James HalleyReady to Buy the Dip? UnitedHealth Group Stock Is a Smart BuyThe healthcare insurer and services giant has a number of advantages.
Sep 23, 2023 by James HalleyAbbott Stock: Bear vs. BullAbbott is a favorite of income-oriented investors, but is the price right?
Sep 21, 2023 by James HalleyWhy Shares of Ambrx Biopharma Soared This WeekA big buy by an asset manager spurred interest in the biotech stock.
Sep 21, 2023 by James HalleyWhy Shares of Neumora Therapeutics Slumped This WeekThe clinical-stage biotech just had its IPO last week.
Sep 21, 2023 by James HalleyWhy Shares of Calliditas Therapeutics Are Rising ThursdayThe company's shares rose in response to a competitors' mixed phase 3 trial.
Sep 21, 2023 by James HalleyWhy Shares of Travere Therapeutics Are Slumping ThursdayA mixed trial could hurt a kidney drug's chances of full approval.
Sep 21, 2023 by James Halley3 Things About Medtronic That Smart Investors KnowMedtronic's history of innovation and dividend growth make for a good combination for investors.
Sep 20, 2023 by James HalleyWhy Shares of ARS Pharmaceuticals Are Plummeting on WednesdayThe company received a Complete Response Letter from the FDA regarding its lead therapy.
Sep 20, 2023 by James HalleyWith New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?All three companies should benefit from increased COVID-19 booster sales.
Sep 19, 2023 by James HalleyWhy Shares of Bausch Health Companies Fell TuesdayThe company announced a chief financial officer transition plan.
Sep 19, 2023 by James HalleyWhy Shares of Orchestra BioMed Jumped TuesdayThe company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.
Sep 18, 2023 by James HalleyWhy Shares of Scilex Are Dropping MondayThe company's shares are being dragged down by its soon-to-be-former parent company.
